These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38581424)

  • 21. Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.
    Martineau P; Finnerty V; Giraldeau G; Authier S; Harel F; Pelletier-Galarneau M
    J Nucl Cardiol; 2021 Feb; 28(1):209-218. PubMed ID: 30834499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy.
    Henein MY; Pilebro B; Lindqvist P
    Heart Vessels; 2022 Sep; 37(9):1562-1569. PubMed ID: 35275264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.
    Singulane C; Sun D; Hu Z; Lee L; Sarswat N; Emami Neyestanak M; Patel AR; Lang RM; Addetia K
    Curr Probl Cardiol; 2024 Sep; 49(9):102729. PubMed ID: 38945183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
    Mori M; An Y; Katayama O; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Murata K; Yokota T; Ando K; Imada K
    Ann Hematol; 2015 Nov; 94(11):1885-90. PubMed ID: 26251157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study.
    Ingebrigtsen A; Saeed S; Larsen TH; Reikvam H
    Scand J Clin Lab Invest; 2024 May; 84(3):193-201. PubMed ID: 38709651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
    Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
    [No Abstract]   [Full Text] [Related]  

  • 28. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
    Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Morgenstern R; Yeh R; Castano A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2018 Oct; 25(5):1559-1567. PubMed ID: 28176254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Amyloidosis: Updates in Imaging.
    Chacko L; Martone R; Cappelli F; Fontana M
    Curr Cardiol Rep; 2019 Aug; 21(9):108. PubMed ID: 31375984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
    Fontana M; Banypersad SM; Treibel TA; Abdel-Gadir A; Maestrini V; Lane T; Gilbertson JA; Hutt DF; Lachmann HJ; Whelan CJ; Wechalekar AD; Herrey AS; Gillmore JD; Hawkins PN; Moon JC
    Radiology; 2015 Nov; 277(2):388-97. PubMed ID: 25997029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.
    Kyriakou P; Mouselimis D; Tsarouchas A; Rigopoulos A; Bakogiannis C; Noutsias M; Vassilikos V
    BMC Cardiovasc Disord; 2018 Dec; 18(1):221. PubMed ID: 30509186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Accuracy of [
    Rosengren S; Skibsted Clemmensen T; Tolbod L; Granstam SO; Eiskjær H; Wikström G; Vedin O; Kero T; Lubberink M; Harms HJ; Flachskampf FA; Baron T; Carlson K; Mikkelsen F; Antoni G; Frost Andersen N; Hvitfeldt Poulsen S; Sörensen J
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1337-1347. PubMed ID: 32417330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep Learning-Enabled Quantification of
    Miller RJH; Shanbhag A; Michalowska AM; Kavanagh P; Liang JX; Builoff V; Fine NM; Dey D; Berman DS; Slomka PJ
    J Nucl Med; 2024 Jul; 65(7):1144-1150. PubMed ID: 38724278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
    Löfbacka V; Suhr OB; Pilebro B; Wixner J; Sundström T; Lindmark K; Anan I; Lindqvist P
    Clin Physiol Funct Imaging; 2021 Sep; 41(5):408-416. PubMed ID: 34033209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
    Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
    JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 39. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.